Abstract
Oxidative stress results from the disruption of the redox system marked by a notable overproduction of reactive oxygen species. There are four major sources of reactive oxygen species, including NADPH oxidases, mitochondria, nitric oxide synthases, and xanthine oxidases. It is well known that renal abnormalities trigger the production of reactive oxygen species by diverse mechanisms under various pathologic stimuli, such as acute kidney injury, chronic kidney disease, nephrotic syndrome, and metabolic disturbances. Mutually, accumulating evidences have identified that oxidative stress plays an essential role in tubulointerstitial fibrosis by myofibroblast activation as well as in glomerulosclerosis by mesangial sclerosis, podocyte abnormality, and parietal epithelial cell injury. Given the involvement of oxidative stress in renal fibrosis, therapies targeting oxidative stress seem promising in renal fibrosis management. In this review, we sketch the updated knowledge of the mechanisms of oxidative stress generation during renal diseases, the pathogenic processes of oxidative stress elicited renal fibrosis and treatments targeting oxidative stress during tubulointerstitial fibrosis and glomerulosclerosis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Andersson-Sjoland A, Karlsson JC, Rydell-Tormanen K (2016) ROS-induced endothelial stress contributes to pulmonary fibrosis through pericytes and Wnt signaling. Lab Invest 96:206–217
Andrades ME, Morina A, Spasic S, Spasojevic I (2011) Bench-to-bedside review: sepsis-from the redox point of view. Critical care (London, England) 15:230
Araujo M, Welch WJ (2006) Oxidative stress and nitric oxide in kidney function. Curr Opin Nephrol Hypertens 15:72–77
Baines RJ, Chana RS, Hall M, Febbraio M, Kennedy D, Brunskill NJ (2012) CD36 mediates proximal tubular binding and uptake of albumin and is upregulated in proteinuric nephropathies. Am J Physiol Renal Physiol 303:F1006–F1014
Baliga R, Ueda N, Walker PD, Shah SV (1999) Oxidant mechanisms in toxic acute renal failure. Drug Metab Rev 31:971–997
Baltanas A, Miguel-Carrasco JL, San Jose G, Cebrian C, Moreno MU, Dotor J et al (2013) A synthetic peptide from transforming growth factor-beta(1) type III receptor inhibits NADPH oxidase and prevents oxidative stress in the kidney of spontaneously hypertensive rats. Antioxid Redox Signal 19:1607–1618
Bas M, Tugcu V, Kemahli E, Ozbek E, Uhri M, Altug T et al (2009) Curcumin prevents shock-wave lithotripsy-induced renal injury through inhibition of nuclear factor kappa-B and inducible nitric oxide synthase activity in rats. Urol Res 37:159–164
Basile DP, Anderson MD, Sutton TA (2012) Pathophysiology of acute kidney injury. Compr. Physiol. 2:1303–1353
Bondi CD, Manickam N, Lee DY, Block K, Gorin Y, Abboud HE et al (2010) NAD(P)H oxidase mediates TGF-beta1-induced activation of kidney myofibroblasts. J Am Soc Nephrol 21:93–102
Bonventre JV, Yang L (2011) Cellular pathophysiology of ischemic acute kidney injury. J Clin Investig 121:4210–4221
Brealey D, Brand M, Hargreaves I, Heales S, Land J, Smolenski R et al (2002) Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 360:219–223
Brown GE, Stewart MQ, Liu H, Ha VL, Yaffe MB (2003) A novel assay system implicates PtdIns(3,4)P(2), PtdIns(3)P, and PKC delta in intracellular production of reactive oxygen species by the NADPH oxidase. Mol Cell 11:35–47
Carlos CP, Mendes GEF, Miquelin AR, Luz MAM, da Silva CGA, van Rooijen N et al (2010) Macrophage depletion attenuates chronic cyclosporine a nephrotoxicity. Transplantation 89:1362–1370
Catherwood MA, Powell LA, Anderson P, McMaster D, Sharpe PC, Trimble ER (2002) Glucose-induced oxidative stress in mesangial cells. Kidney Int 61:599–608
Cha JJ, Min HS, Kim KT, Kim JE, Ghee JY, Kim HW et al (2017) APX-115, a first-in-class pan-NADPH oxidase (Nox) inhibitor, protects db/db mice from renal injury. Lab Invest 97:419
Chen J, Chen JK, Harris RC (2012a) Angiotensin II induces epithelial-to-mesenchymal transition in renal epithelial cells through reactive oxygen species/Src/caveolin-mediated activation of an epidermal growth factor receptor-extracellular signal-regulated kinase signaling pathway. Mol Cell Biol 32:981–991
Chen YQ, Wang XX, Yao XM, Zhang DL, Yang XF, Tian SF et al (2012b) Abated microRNA-195 expression protected mesangial cells from apoptosis in early diabetic renal injury in mice. J Nephrol 25:566–576
Chen JF, Liu H, Ni HF, Lv LL, Zhang MH, Zhang AH et al (2013) Improved mitochondrial function underlies the protective effect of pirfenidone against tubulointerstitial fibrosis in 5/6 nephrectomized rats. PLoS ONE 8:e83593
Chirino YI, Pedraza-Chaverri J (2009) Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity. Exp Toxicol Pathol: Off J Ges Fur Toxikol Pathol 61:223–242
Choi BH, Kang KS, Kwak MK (2014) Effect of redox modulating NRF2 activators on chronic kidney disease. Molecules (Basel, Switzerland) 19:12727–12759
Civantos E, Bosch E, Ramirez E, Zhenyukh O, Egido J, Lorenzo O et al (2017) Sitagliptin ameliorates oxidative stress in experimental diabetic nephropathy by diminishing the miR-200a/Keap-1/Nrf2 antioxidant pathway. Diabetes, MetabIc Syndr Obes: Targets Ther 10:207–222
De Blasio MJ, Ramalingam A, Cao AH, Prakoso D, Ye JM, Pickering R et al (2017) The superoxide dismutase mimetic tempol blunts diabetes-induced upregulation of NADPH oxidase and endoplasmic reticulum stress in a rat model of diabetic nephropathy. Eur J Pharmacol 807:12–20
Decleves AE, Sharma K (2014) Novel targets of antifibrotic and anti-inflammatory treatment in CKD. Nature reviews Nephrology 10:257–267
Dendooven A, van Oostrom O, van der Giezen DM, Leeuwis JW, Snijckers C, Joles JA et al (2011) Loss of endogenous bone morphogenetic protein-6 aggravates renal fibrosis. Am J Pathol 178:1069–1079
Dou L, Jourde-Chiche N, Faure V, Cerini C, Berland Y, Dignat-George F et al (2007) The uremic solute indoxyl sulfate induces oxidative stress in endothelial cells. J Thromb Haemost: JTH 5:1302–1308
Echeverria C, Montorfano I, Sarmiento D, Becerra A, Nunez-Villena F, Figueroa XF et al (2013) Lipopolysaccharide induces a fibrotic-like phenotype in endothelial cells. J Cell Mol Med 17:800–814
Eng DG, Sunseri MW, Kaverina NV, Roeder SS, Pippin JW, Shankland SJ (2015) Glomerular parietal epithelial cells contribute to adult podocyte regeneration in experimental focal segmental glomerulosclerosis. Kidney Int 88:999–1012
Fassett RG, Robertson IK, Ball MJ, Geraghty DP, Coombes JS (2015) Effects of atorvastatin on oxidative stress in chronic kidney disease. Nephrology (Carlton, Vic) 20:697–705
Forstermann U, Munzel T (2006) Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation 113:1708–1714
Gill PS, Wilcox CS (2006) NADPH oxidases in the kidney. Antioxid Redox Signal 8:1597–1607
Gill R, Tsung A, Billiar T (2010) Linking oxidative stress to inflammation: toll-like receptors. Free Radic Biol Med 48:1121–1132
Gorin Y, Cavaglieri RC, Khazim K, Lee DY, Bruno F, Thakur S et al (2015) Targeting NADPH oxidase with a novel dual Nox1/Nox4 inhibitor attenuates renal pathology in type 1 diabetes. Am J Physiol Renal Physiol 308:F1276–F1287
Handy DE, Loscalzo J (2012) Redox regulation of mitochondrial function. Antioxid Redox Signal 16:1323–1367
He T, Guan X, Wang S, Xiao T, Yang K, Xu X et al (2015) Resveratrol prevents high glucose-induced epithelial-mesenchymal transition in renal tubular epithelial cells by inhibiting NADPH oxidase/ROS/ERK pathway. Mol Cell Endocrinol 402:13–20
He T, Xiong J, Nie L, Yu Y, Guan X, Xu X et al (2016) Resveratrol inhibits renal interstitial fibrosis in diabetic nephropathy by regulating AMPK/Nox4/ROS pathway. J Mol Med (Berl, Ger) 94:1359–1371
Hong YA, Lim JH, Kim MY, Kim EN, Koh ES, Shin SJ et al (2014) Delayed treatment with oleanolic acid attenuates tubulointerstitial fibrosis in chronic cyclosporine nephropathy through Nrf2/HO-1 signaling. J Transl Med 12:50
Jefferson JA, Shankland SJ (2014) The pathogenesis of focal segmental glomerulosclerosis. Adv Chronic Kidney Dis 21:408–416
Jha JC, Gray SP, Barit D, Okabe J, El-Osta A, Namikoshi T et al (2014) Genetic targeting or pharmacologic inhibition of NADPH oxidase Nox4 provides renoprotection in long-term diabetic nephropathy. J Am Soc Nephrol 25:1237–1254
Jimenez-Osorio AS, Garcia-Nino WR, Gonzalez-Reyes S, Alvarez-Mejia AE, Guerra-Leon S, Salazar-Segovia J et al (2016) The effect of dietary supplementation with curcumin on redox status and Nrf2 activation in patients with nondiabetic or diabetic proteinuric chronic kidney disease: a pilot study. J Ren Nutr: Off J Counc Ren Nutr Natl Kidney Found 26:237–244
Jones DP (2006) Redefining oxidative stress. Antioxid Redox Signal 8:1865–1879
Katagiri D, Hamasaki Y, Doi K, Negishi K, Sugaya T, Nangaku M et al (2016) Interstitial renal fibrosis due to multiple cisplatin treatments is ameliorated by semicarbazide-sensitive amine oxidase inhibition. Kidney Int 89:374–385
Kida Y, Tchao BN, Yamaguchi I (2014) Peritubular capillary rarefaction: a new therapeutic target in chronic kidney disease. Pediatr Nephrol 29:333–342
Kim JH, Kim BK, Moon KC, Hong HK, Lee HS (2003) Activation of the TGF-/Smad signaling pathway in focal segmental glomerulosclerosis. Kidney Int 64:1715–1721
Kim SM, Kim YG, Jeong KH, Lee SH, Lee TW, Ihm CG et al (2012) Angiotensin II-induced mitochondrial Nox4 is a major endogenous source of oxidative stress in kidney tubular cells. PLoS ONE 7:e39739
Kim S, Kim SJ, Yoon HE, Chung S, Choi BS, Park CW et al (2015) Fimasartan, a novel angiotensin-receptor blocker, protects against renal inflammation and fibrosis in mice with unilateral ureteral obstruction: the possible Role of Nrf2. Int J Med Sci 12:891–904
Krause KH (2007) Aging: a revisited theory based on free radicals generated by Nox family NADPH oxidases. Exp Gerontol 42:256–262
Lassègue B, Clempus RE (2003) Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol 285:R277–297
Lee DY, Wauquier F, Eid AA, Roman LJ, Ghosh-Choudhury G, Khazim K et al (2013) Nox4 NADPH oxidase mediates peroxynitrite-dependent uncoupling of endothelial nitric-oxide synthase and fibronectin expression in response to angiotensin II: role of mitochondrial reactive oxygen species. J Biol Chem 288:28668–28686
Lee WJ, Liu SH, Chiang CK, Lin SY, Liang KW, Chen CH et al (2016) Aryl hydrocarbon receptor deficiency attenuates oxidative stress-related mesangial cell activation and macrophage infiltration and extracellular matrix accumulation in diabetic nephropathy. Antioxid Redox Signal 24:217–231
Leo CH, Jelinic M, Ng HH, Marshall SA (2017) Vascular actions of relaxin: nitric oxide and beyond. Br J Pharmacol 174:1002–1014
Lichtenberg D, Pinchuk I (2015) Oxidative stress, the term and the concept. Biochem Biophys Res Commun 461:441–444
Lin EY, Bayarsengee U, Wang CC, Chiang YH, Cheng CW (2018) The natural compound 2,3,5,4’-tetrahydroxystilbene-2-O-beta-d glucoside protects against adriamycin-induced nephropathy through activating the Nrf2-Keap1 antioxidant pathway. Environ Toxicol 33:72–82
Liu G, Shi Y, Peng X, Liu H, Peng Y, He L (2015) Astaxanthin attenuates adriamycin-induced focal segmental glomerulosclerosis. Pharmacology 95:193–200
Lorenz G, Darisipudi MN, Anders HJ (2014) Canonical and non-canonical effects of the NLRP3 inflammasome in kidney inflammation and fibrosis. Nephrol Dial Transplant 29:41–48
Lu Q, Zhou Y, Hao M, Li C, Wang J, Shu F et al (2017) The mTOR promotes oxidative stress-induced apoptosis of mesangial cells in diabetic nephropathy. Mol Cell Endocrinol 473:31–43
Lushchak VI (2014) Free radicals, reactive oxygen species, oxidative stress and its classification. Chem Biol Interact 224:164–175
Lv W, Booz GW, Fan F, Wang Y, Roman RJ (2018) Oxidative stress and renal fibrosis: recent insights for the development of novel therapeutic strategies. Front Physiol 9:105
Madero M, Sarnak MJ, Wang X, Greene T, Beck GJ, Kusek JW et al (2009) Uric acid and long-term outcomes in CKD. Am J Kidney Dis 53:796–803
Martinon F, Pétrilli V, Mayor A, Tardivel A, Tschopp J (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440:237–241
Mason RM (2003) Extracellular matrix metabolism in diabetic nephropathy. J Am Soc Nephrol 14:1358–1373
Massy ZA, Ceballos I, Chadefaux-Vekemens B, Nguyen-Khoa T, Descamps-Latscha B, Drueke TB et al (2001) Homocyst(e)ine, oxidative stress, and endothelium function in uremic patients. Kidney Int Suppl 78:S243–S245
Meotti FC, Jameson GN, Turner R, Harwood DT, Stockwell S, Rees MD et al (2011) Urate as a physiological substrate for myeloperoxidase: implications for hyperuricemia and inflammation. J Biol Chem 286:12901–12911
Montorfano I, Becerra A, Cerro R, Echeverria C, Saez E, Morales MG et al (2014) Oxidative stress mediates the conversion of endothelial cells into myofibroblasts via a TGF-beta1 and TGF-beta2-dependent pathway. Lab Invest 94:1068–1082
Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y et al (2000) Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404:787–790
Nishikimi T, Matsuoka H (2006) Molecular mechanisms and therapeutic strategies of chronic renal injury: renoprotective effect of rho-kinase inhibitor in hypertensive glomerulosclerosis. J Pharmacol Sci 100:22–28
Noh H, Kim JS, Han KH, Lee GT, Song JS, Chung SH et al (2006) Oxidative stress during peritoneal dialysis: implications in functional and structural changes in the membrane. Kidney Int 69:2022–2028
Oberg BP, McMenamin E, Lucas FL, McMonagle E, Morrow J, Ikizler TA et al (2004) Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int 65:1009–1016
Okamura DM, Pennathur S (2015) The balance of powers: redox regulation of fibrogenic pathways in kidney injury. Redox biology 6:495–504
Okamura DM, Bahrami NM, Ren S, Pasichnyk K, Williams JM, Gangoiti JA et al (2014) Cysteamine modulates oxidative stress and blocks myofibroblast activity in CKD. J Am Soc Nephrol 25:43–54
Pacher P, Nivorozhkin A, Szabo C (2006) Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacol Rev 58:87–114
Qiao M, Zhao Q, Lee CF, Tannock LR, Smart EJ, LeBaron RG et al (2009) Thiol oxidative stress induced by metabolic disorders amplifies macrophage chemotactic responses and accelerates atherogenesis and kidney injury in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 29:1779–1786
Qiao Y, Xu L, Tao X, Yin L, Qi Y, Xu Y et al (2018) Protective effects of dioscin against fructose-induced renal damage via adjusting Sirt3-mediated oxidative stress, fibrosis, lipid metabolism and inflammation. Toxicol Lett 284:37–45
Qin J, Xie YY, Huang L, Yuan QJ, Mei WJ, Yuan XN et al (2013) Fluorofenidone inhibits nicotinamide adenine dinucleotide phosphate oxidase via PI3 K/Akt pathway in the pathogenesis of renal interstitial fibrosis. Nephrology (Carlton, Vic) 18:690–699
Radi R (2013) Peroxynitrite, a stealthy biological oxidant. J Biol Chem 288:26464–26472
Ralto KM, Parikh SM (2016) Mitochondria in acute kidney injury. Semin Nephrol 36:8–16
Ratliff BB, Abdulmahdi W, Pawar R, Wolin MS (2016) Oxidant mechanisms in renal injury and disease. Antioxid Redox Signal 25:119–146
Sakai N, Wada T, Yokoyama H, Lipp M, Ueha S, Matsushima K et al (2006) Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR72 signaling regulates fibrocytes in renal fibrosis. Proc Natl Acad Sci 103:14098–14103
Sánchez-Lozada LG, Lanaspa MA, Cristóbal-GarcÃa M, GarcÃa-Arroyo F, Soto V, Cruz-Robles D et al (2012) Uric acid-induced endothelial dysfunction is associated with mitochondrial alterations and decreased intracellular ATP concentrations. Nephron Exp Nephrol 121:e71–78
Sasser JM (2013) The emerging role of relaxin as a novel therapeutic pathway in the treatment of chronic kidney disease. Am J Physiol Regul Integr Comp Physiol 305:R559–R565
Sedeek M, Nasrallah R, Touyz RM, Hebert RL (2013) NADPH oxidases, reactive oxygen species, and the kidney: friend and foe. J Am Soc Nephrol 24:1512–1518
Seifert EL, Estey C, Xuan JY, Harper ME (2010) Electron transport chain-dependent and -independent mechanisms of mitochondrial H2O2 emission during long-chain fatty acid oxidation. J Biol Chem 285:5748–5758
Shahzad K, Bock F, Dong W, Wang H, Kopf S, Kohli S et al (2015) Nlrp3- inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy. Kidney Int 87:74–84
Shankland SJ, Anders HJ, Romagnani P (2013) Glomerular parietal epithelial cells in kidney physiology, pathology, and repair. Curr Opin Nephrol Hypertens 22:302–309
Sies H (1985) Oxidative stress: introductory remarks. Oxidative stress. Academic press, London, pp 1–8
Sitar ME, Aydin S, Cakatay U (2013) Human serum albumin and its relation with oxidative stress. Clinical laboratory 59:945–952
Smeets B, Kuppe C, Sicking EM, Fuss A, Jirak P, van Kuppevelt TH et al (2011) Parietal epithelial cells participate in the formation of sclerotic lesions in focal segmental glomerulosclerosis. J Am Soc Nephrol 22:1262–1274
Soetikno V, Sari FR, Lakshmanan AP, Arumugam S, Harima M, Suzuki K et al (2013) Curcumin alleviates oxidative stress, inflammation, and renal fibrosis in remnant kidney through the Nrf2-keap1 pathway. Mol Nutr Food Res 57:1649–1659
Su H, Chen S, He FF, Wang YM, Bondzie P, Zhang C (2015) New insights into glomerular parietal epithelial cell activation and its signaling pathways in glomerular diseases. Biomed Res Int 2015:318935
Su H, Wan C, Lei CT, Zhang CY, Ye C, Tang H et al (2017) Lipid deposition in kidney disease: interplay among redox, lipid mediators, and renal impairment. Antioxid Redox Signal 28:1027–1043
Tang DQ, Wei YQ, Yin XX, Lu Q, Hao HH, Zhai YP et al (2011) In vitro suppression of quercetin on hypertrophy and extracellular matrix accumulation in rat glomerular mesangial cells cultured by high glucose. Fitoterapia 82:920–926
Tapia E, Garcia-Arroyo F, Silverio O, Rodriguez-Alcocer AN, Jimenez-Flores AB, Cristobal M et al (2016) Mycophenolate mofetil and curcumin provide comparable therapeutic benefit in experimental chronic kidney disease: role of Nrf2-Keap1 and renal dopamine pathways. Free Radical Res 50:781–792
Tbahriti HF, Kaddous A, Bouchenak M, Mekki K (2013) Effect of different stages of chronic kidney disease and renal replacement therapies on oxidant-antioxidant balance in uremic patients. Biochem Res Int 2013:358985
Tripathy D, Mohanty P, Dhindsa S, Syed T, Ghanim H, Aljada A et al (2003) Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects. Diabetes 52:2882–2887
Tsuda H, Kawada N, Kaimori J, Kitamura H, Moriyama T, Rakugi H et al (2012) Febuxostat suppressed renal ischemia-reperfusion injury via reduced oxidative stress. Biochem Biophys Res Commun 427:266–272
Tugcu V, Bas M, Ozbek E, Kemahli E, Arinci YV, Tuhri M et al (2008) Pyrolidium dithiocarbamate prevents shockwave lithotripsy-induced renal injury through inhibition of nuclear factor-kappa B and inducible nitric oxide synthase activity in rats. J Endourol 22:559–566
Tumur Z, Shimizu H, Enomoto A, Miyazaki H, Niwa T (2010) Indoxyl sulfate upregulates expression of ICAM-1 and MCP-1 by oxidative stress-induced NF-kappaB activation. Am J Nephrol 31:435–441
Tuttle KR, Bakris GL, Bilous RW, Chiang JL, de Boer IH, Goldstein-Fuchs J et al (2014) Diabetic kidney disease: a report from an ADA Consensus Conference. Diabetes Care 37:2864–2883
Wagner B, Tan C, Barnes JL, Ahuja S, Davis TL, Gorin Y et al (2012) Nephrogenic systemic fibrosis: evidence for oxidative stress and bone marrow-derived fibrocytes in skin, liver, and heart lesions using a 5/6 nephrectomy rodent model. Am J Pathol 181:1941–1952
Wan C, Su H, Zhang C (2016) Role of NADPH oxidase in metabolic disease-related renal injury: an update. Oxid Med Cell Longev 2016:7813072
Wang JY, Yin XX, Wu YM, Tang DQ, Gao YY, Wan MR et al (2006) Ginkgo biloba extract suppresses hypertrophy and extracellular matrix accumulation in rat mesangial cells. Acta Pharmacol Sin 27:1222–1230
Ward RA, McLeish KR (2003) Oxidant stress in hemodialysis patients: what are the determining factors? Artif Organs 27:230–236
Ward RA, Ouseph R, McLeish KR (2003) Effects of high-flux hemodialysis on oxidant stress. Kidney Int 63:353–359
Yang Z-Z, Zou A-P (2003) Homocysteine enhances TIMP-1 expression and cell proliferation associated with NADH oxidase in rat mesangial cells. Kidney Int 63:1012–1020
Yang S, Zhao L, Han Y, Liu Y, Chen C, Zhan M et al (2017) Probucol ameliorates renal injury in diabetic nephropathy by inhibiting the expression of the redox enzyme p66Shc. Redox biology 13:482–497
Zhao H, Liu YJ, Liu ZR, Tang DD, Chen XW, Chen YH et al (2017) Role of mitochondrial dysfunction in renal fibrosis promoted by hypochlorite-modified albumin in a remnant kidney model and protective effects of antioxidant peptide SS-31. Eur J Pharmacol 804:57–67
Zschiedrich S, Bork T, Liang W, Wanner N, Eulenbruch K, Munder S et al (2017) Targeting mTOR signaling can prevent the progression of FSGS. J Am Soc Nephrol 28:2144–2157
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Su, H., Wan, C., Song, A., Qiu, Y., Xiong, W., Zhang, C. (2019). Oxidative Stress and Renal Fibrosis: Mechanisms and Therapies. In: Liu, BC., Lan, HY., Lv, LL. (eds) Renal Fibrosis: Mechanisms and Therapies. Advances in Experimental Medicine and Biology, vol 1165. Springer, Singapore. https://doi.org/10.1007/978-981-13-8871-2_29
Download citation
DOI: https://doi.org/10.1007/978-981-13-8871-2_29
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-8870-5
Online ISBN: 978-981-13-8871-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)